A/H5N1 Avian Influenza Vaccine: Phase I started

Novavax began 2 single-blind, placebo-controlled, dose-ranging, U.S. Phase I trials to evaluate intramuscular A/H5N1 Avian Influenza Vaccine given 21 days apart with or without an undisclosed adjuvant...